Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2022 Filed Jan 10, 2022 22:13 UTC |
Souza FabianSVP & Controller
|
Exercise / conversion2021 Restricted Stock Units · Derivative | 1,710 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000882 · form4.xml · derivative · entry 5 Souza Fabian · CIK 0001644567 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,421 Underlying: Common Stock · 1,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F5 · balance_after: The RSU award accrued 160 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:13 UTC |
Souza FabianSVP & Controller
|
Exercise / conversion2020 Restricted Stock Units · Derivative | 1,630 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000882 · form4.xml · derivative · entry 4 Souza Fabian · CIK 0001644567 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,630 Underlying: Common Stock · 1,630 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F4 · balance_after: The RSU award accrued 102 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:13 UTC |
Souza FabianSVP & Controller
|
Exercise / conversion2019 Restricted Stock Units · Derivative | 1,679 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001062993-22-000882 · form4.xml · derivative · entry 3 Souza Fabian · CIK 0001644567 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,679 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.exercise_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F2 · derivative.expiration_date: Vesting of previously granted restricted stock unit (RSU) awarded under Exelon Long Term Incentive Plan. Awards granted annually to vest in 1/3 increments at the January or February meetings of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. RSUs accrue quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award. F3 · balance_after: The RSU award accrued 52 additional shares during 2021 through automatic dividend reinvestment. Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:13 UTC |
Souza FabianSVP & Controller
|
Tax withholdingCommon Stock | 1,800 | $56.73 | $102,114.00 |
DisclosureSEC source: 0001062993-22-000882 · form4.xml · nonDerivative · entry 2 Souza Fabian · CIK 0001644567 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,737 Read SEC document |
| January 06, 2022 Filed Jan 10, 2022 22:13 UTC |
Souza FabianSVP & Controller
|
Exercise / conversionCommon Stock | 5,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-000882 · form4.xml · nonDerivative · entry 1 Souza Fabian · CIK 0001644567 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Common shares acquired through conversion of previously awarded and vested restricted stock units (RSUs) under the Exelon Long Term Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:10 UTC |
SHATTUCK MAYO A IIIDirector · Chairman of the Board
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000058 · form4.xml · nonDerivative · entry 1 SHATTUCK MAYO A III · CIK 0001087426 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors Deferred Stock Unit Plan Disclosed balance after: 34,922 F1 · balance_after: Balance includes 241 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:10 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 531 | $53.91 | $28,626.21 |
DisclosureSEC source: 0001062993-22-000060 · form4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Director's Deferred Stock Unit Plan Disclosed balance after: 531 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:09 UTC |
Richardson John MDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000057 · form4.xml · nonDerivative · entry 1 Richardson John M · CIK 0001786800 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 8,522 F1 · balance_after: Balance includes 55 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:10 UTC |
YOUNG JOHN FDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000059 · form4.xml · nonDerivative · entry 1 YOUNG JOHN F · CIK 0001230766 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 12,526 F1 · balance_after: Balance includes 83 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:09 UTC |
LAWLESS ROBERT JDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 801 | $57.76 | $46,265.76 |
DisclosureSEC source: 0001062993-22-000056 · form4.xml · derivative · entry 4 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,590 Underlying: Common Stock · 801 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 259 shares equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · derivative.exercise_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 259 shares equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · derivative.expiration_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 259 shares equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · balance_after: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 259 shares equivalents accrued on November 12, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:09 UTC |
LAWLESS ROBERT JDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000056 · form4.xml · nonDerivative · entry 1 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 38,933 F1 · balance_after: Balance includes 269 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:08 UTC |
JOSKOW PAUL LDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000055 · form4.xml · nonDerivative · entry 1 JOSKOW PAUL L · CIK 0001196502 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 53,528 F1 · balance_after: Balance includes 372 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:07 UTC |
Jojo Linda PDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000054 · form4.xml · nonDerivative · entry 1 Jojo Linda P · CIK 0001296796 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 24,777 F1 · balance_after: Balance includes 169 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:07 UTC |
DE BALMANN YVES CDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000053 · form4.xml · nonDerivative · entry 1 DE BALMANN YVES C · CIK 0001257061 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 38,933 F1 · balance_after: Balance includes 269 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:07 UTC |
Cheshire Marjorie RodgersDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 251 | $57.76 | $14,497.76 |
DisclosureSEC source: 0001062993-22-000052 · form4.xml · derivative · entry 2 Cheshire Marjorie Rodgers · CIK 0001621713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,661 Underlying: Common Stock · 251 shares Expires not disclosed F2 · derivative.exercise_price: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 10 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F2 · derivative.exercise_date: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 10 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F2 · derivative.expiration_date: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 10 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F2 · derivative.underlying_shares: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 10 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F2 · balance_after: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 10 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:07 UTC |
Cheshire Marjorie RodgersDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000052 · form4.xml · nonDerivative · entry 1 Cheshire Marjorie Rodgers · CIK 0001621713 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 5,023 F1 · balance_after: Balance includes 30 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:06 UTC |
BRLAS LAURIEDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000051 · form4.xml · nonDerivative · entry 1 BRLAS LAURIE · CIK 0001235612 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 11,700 F1 · balance_after: Balance includes 77 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:06 UTC |
BOWERS WILLIAM PDirector
|
GrantCommmon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000050 · form4.xml · nonDerivative · entry 1 BOWERS WILLIAM P · CIK 0001225760 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors Deferred Stock Unit Plan Disclosed balance after: 1,280 F1 · balance_after: Balance includes 4 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:05 UTC |
BERZIN ANN CDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 656 | $57.76 | $37,890.56 |
DisclosureSEC source: 0001062993-22-000049 · form4.xml · derivative · entry 3 BERZIN ANN C · CIK 0001215820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,105 Underlying: Common Stock · 656 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 263 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · derivative.exercise_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 263 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · derivative.expiration_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 263 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. F3 · balance_after: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 263 share equivalents accrued on November 12, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:05 UTC |
BERZIN ANN CDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000049 · form4.xml · nonDerivative · entry 1 BERZIN ANN C · CIK 0001215820 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 38,933 F1 · balance_after: Balance includes 269 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:05 UTC |
Anderson AnthonyDirector
|
GrantCommon Stock (Deferred Stock Units) | 719 | $53.91 | $38,761.29 |
DisclosureSEC source: 0001062993-22-000047 · form4.xml · nonDerivative · entry 1 Anderson Anthony · CIK 0001559294 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 35,252 F1 · balance_after: Balance includes 243 shares acquired on December 10, 2021 through automatic dividend reinvestment. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:58 UTC |
MCHUGH JAMESEVP & Chief Commercial Officer
|
GrantDeferred Phantom Shares · Derivative | 40 | $54.69 | $2,187.60 |
DisclosureSEC source: 0001062993-21-013012 · form4.xml · derivative · entry 1 MCHUGH JAMES · CIK 0001897905 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,213 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. F1 · derivative.exercise_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. F1 · derivative.expiration_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. F1 · balance_after: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 18:00 UTC |
Dominguez JosephCEO, Exelon Generation
|
Exercise / conversionNQ Stock Option (right to buy) 03/12/2012 · Derivative | 16,000 | Not disclosed Strike: $39.81 | Not disclosed |
DisclosureSEC source: 0001062993-21-011682 · form4.xml · derivative · entry 3 Dominguez Joseph · CIK 0001495634 · CEO, Exelon Generation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale made pursuant to a Rule 10b5-1 trading plan entered into by Mr. Dominguez on November 10, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.exercise_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.expiration_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 18:00 UTC |
Dominguez JosephCEO, Exelon Generation
|
SaleCommon Stock | 16,000 | $54.39 | $870,240.00 |
DisclosureSEC source: 0001062993-21-011682 · form4.xml · nonDerivative · entry 2 Dominguez Joseph · CIK 0001495634 · CEO, Exelon Generation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,821 F1 · kind: Exercise and sale made pursuant to a Rule 10b5-1 trading plan entered into by Mr. Dominguez on November 10, 2021. F2 · price: Shares sold in individual lots with prices ranging from $54.01 to $54.64 inclusive. Mr. Dominguez undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission full details of the number of shares sold at each individual price within the range provided above. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 18:00 UTC |
Dominguez JosephCEO, Exelon Generation
|
Exercise / conversionCommon Stock | 16,000 | $39.81 | $636,960.00 |
DisclosureSEC source: 0001062993-21-011682 · form4.xml · nonDerivative · entry 1 Dominguez Joseph · CIK 0001495634 · CEO, Exelon Generation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale made pursuant to a Rule 10b5-1 trading plan entered into by Mr. Dominguez on November 10, 2021. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC |
Crane Christopher M.President & CEO
|
Exercise / conversionNQ Stock Option (right to buy) 04/02/2012 · Derivative | 285,000 | Not disclosed Strike: $39.21 | Not disclosed |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · derivative · entry 5 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 285,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.exercise_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.expiration_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC |
Crane Christopher M.President & CEO
|
SaleCommon Stock | 285,000 | $53.49 | $15,244,650.00 |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · nonDerivative · entry 2 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,323 F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F2 · price: Shares were sold in multiple lots with prices ranging from $53.22 to $53.79 inclusive. Mr Crane undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at at each separate price within the range provided above. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:26 UTC |
Crane Christopher M.President & CEO
|
Exercise / conversionCommon Stock | 285,000 | $39.21 | $11,174,850.00 |
DisclosureSEC source: 0001062993-21-011390 · form4.xml · nonDerivative · entry 1 Crane Christopher M. · CIK 0001411453 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 774,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares were made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Crane on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:27 UTC |
Nigro JosephSr. EVP & Chief Fin. Officer
|
Exercise / conversionNQ Stock Option (right to buy) 03/12/2012 · Derivative | 13,000 | Not disclosed Strike: $39.81 | Not disclosed |
DisclosureSEC source: 0001062993-21-011391 · form4.xml · derivative · entry 3 Nigro Joseph · CIK 0001740087 · Sr. EVP & Chief Fin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Nigro on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.exercise_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. F3 · derivative.expiration_date: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:27 UTC |
Nigro JosephSr. EVP & Chief Fin. Officer
|
SaleCommon Stock | 13,000 | $53.49 | $695,370.00 |
DisclosureSEC source: 0001062993-21-011391 · form4.xml · nonDerivative · entry 2 Nigro Joseph · CIK 0001740087 · Sr. EVP & Chief Fin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,752 F1 · kind: Exercise and sale of shares made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Nigro on November 5, 2021. F2 · price: Shares were sold in multiple lots with prices ranging from $53.24 to $53.79 inclusive. Mr Nigro undertakes to provide to Exelon Corporation, any security holder of Exelon Corporation or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at at each separate price within the range provided above. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 23:27 UTC |
Nigro JosephSr. EVP & Chief Fin. Officer
|
Exercise / conversionCommon Stock | 13,000 | $39.81 | $517,530.00 |
DisclosureSEC source: 0001062993-21-011391 · form4.xml · nonDerivative · entry 1 Nigro Joseph · CIK 0001740087 · Sr. EVP & Chief Fin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Exercise and sale of shares made pursuant to a Rule 10b5-1 Trading Plan entered into by Mr. Nigro on November 5, 2021. F3 · price: Fully vested non-qualified stock option granted pursuant to the Exelon Long-Term Incentive Plan. Option award will expire on the 10th anniversary of the grant date referenced in column 1. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:13 UTC |
SHATTUCK MAYO A IIIDirector · Chairman of the Board
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009069 · form4.xml · nonDerivative · entry 1 SHATTUCK MAYO A III · CIK 0001087426 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors Deferred Stock Unit Plan Disclosed balance after: 33,962 F1 · balance_after: Balance includes 252 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:13 UTC |
YOUNG JOHN FDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009070 · form4.xml · nonDerivative · entry 1 YOUNG JOHN F · CIK 0001230766 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 11,724 F1 · balance_after: Balance includes 83 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:13 UTC |
Richardson John MDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009068 · form4.xml · nonDerivative · entry 1 Richardson John M · CIK 0001786800 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 7,748 F1 · balance_after: Balance includes 53 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:12 UTC |
LAWLESS ROBERT JDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 957 | $48.34 | $46,261.38 |
DisclosureSEC source: 0001062993-21-009067 · form4.xml · derivative · entry 4 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,599 Underlying: Common Stock · 957 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 285 shares equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · derivative.exercise_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 285 shares equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · derivative.expiration_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 285 shares equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · balance_after: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 285 shares equivalents accrued on August 12, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:12 UTC |
LAWLESS ROBERT JDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009067 · form4.xml · nonDerivative · entry 1 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 37,945 F1 · balance_after: Balance includes 283 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:12 UTC |
Jojo Linda PDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009065 · form4.xml · nonDerivative · entry 1 Jojo Linda P · CIK 0001296796 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 23,888 F1 · balance_after: Balance includes 176 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:12 UTC |
JOSKOW PAUL LDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009066 · form4.xml · nonDerivative · entry 1 JOSKOW PAUL L · CIK 0001196502 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 52,437 F1 · balance_after: Balance includes 393 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
DE BALMANN YVES CDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009064 · form4.xml · nonDerivative · entry 1 DE BALMANN YVES C · CIK 0001257061 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 37,945 F1 · balance_after: Balance includes 283 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
Cheshire Marjorie RodgersDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 274 | $48.34 | $13,245.16 |
DisclosureSEC source: 0001062993-21-009063 · form4.xml · derivative · entry 2 Cheshire Marjorie Rodgers · CIK 0001621713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403 Underlying: Common Stock · 274 shares Expires not disclosed F2 · derivative.exercise_price: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 9 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F2 · derivative.exercise_date: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 9 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F2 · derivative.expiration_date: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 9 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F2 · derivative.underlying_shares: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 9 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F2 · balance_after: Phantom share equivalents in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 9 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
Cheshire Marjorie RodgersDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009063 · form4.xml · nonDerivative · entry 1 Cheshire Marjorie Rodgers · CIK 0001621713 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 4,274 F1 · balance_after: Balance includes 27 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
BERZIN ANN CDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 817 | $48.34 | $39,493.78 |
DisclosureSEC source: 0001062993-21-009060 · form4.xml · derivative · entry 3 BERZIN ANN C · CIK 0001215820 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,256 Underlying: Common Stock · 817 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 292 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · derivative.exercise_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 292 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · derivative.expiration_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 292 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. F3 · balance_after: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service. Balance also reflects 292 share equivalents accrued on August 12, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
BERZIN ANN CDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009060 · form4.xml · nonDerivative · entry 1 BERZIN ANN C · CIK 0001215820 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 37,945 F1 · balance_after: Balance includes 283 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:11 UTC |
BOWERS WILLIAM PDirector
|
GrantCommmon Stock (Deferred Stock Units) | 557 | $49.91 | $27,799.87 |
DisclosureSEC source: 0001062993-21-009062 · form4.xml · nonDerivative · entry 1 BOWERS WILLIAM P · CIK 0001225760 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors Deferred Stock Unit Plan Disclosed balance after: 557 Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:10 UTC |
BRLAS LAURIEDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009061 · form4.xml · nonDerivative · entry 1 BRLAS LAURIE · CIK 0001235612 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 10,904 F1 · balance_after: Balance includes 77 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:09 UTC |
Anderson AnthonyDirector
|
GrantCommon Stock (Deferred Stock Units) | 776 | $49.91 | $38,730.16 |
DisclosureSEC source: 0001062993-21-009059 · form4.xml · nonDerivative · entry 1 Anderson Anthony · CIK 0001559294 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 34,290 F1 · balance_after: Balance includes 255 shares acquired on September 10, 2021 through automatic dividend reinvestment. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:17 UTC |
SHATTUCK MAYO A IIIDirector · Chairman of the Board
|
GrantCommon Stock (Deferred Stock Units) | 830 | $46.71 | $38,769.30 |
DisclosureSEC source: 0001062993-21-006201 · form4.xml · nonDerivative · entry 1 SHATTUCK MAYO A III · CIK 0001087426 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors Deferred Stock Unit Plan Disclosed balance after: 32,933 F1 · balance_after: Balance includes 261 shares acquired on June 10, 2021 through automatic dividend reinvestment. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:18 UTC |
YOUNG JOHN FDirector
|
GrantCommon Stock (Deferred Stock Units) | 830 | $46.71 | $38,769.30 |
DisclosureSEC source: 0001062993-21-006202 · form4.xml · nonDerivative · entry 1 YOUNG JOHN F · CIK 0001230766 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 10,864 F1 · balance_after: Balance includes 82 shares acquired on June 10, 2021 through automatic dividend reinvestment. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:16 UTC |
LAWLESS ROBERT JDirector
|
GrantDeferred Compensation - Phantom Share Equivalents · Derivative | 1,044 | $44.31 | $46,259.64 |
DisclosureSEC source: 0001062993-21-006199 · form4.xml · derivative · entry 4 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,453 Underlying: Common Stock · 1,044 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 296 shares equivalents accrued on May 13, 2021 through automatic dividend reinvestment. F3 · derivative.exercise_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 296 shares equivalents accrued on May 13, 2021 through automatic dividend reinvestment. F3 · derivative.expiration_date: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 296 shares equivalents accrued on May 13, 2021 through automatic dividend reinvestment. F3 · balance_after: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 296 shares equivalents accrued on May 13, 2021 through automatic dividend reinvestment. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:16 UTC |
LAWLESS ROBERT JDirector
|
GrantCommon Stock (Deferred Stock Units) | 830 | $46.71 | $38,769.30 |
DisclosureSEC source: 0001062993-21-006199 · form4.xml · nonDerivative · entry 1 LAWLESS ROBERT J · CIK 0001164638 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 36,886 F1 · balance_after: Balance includes 293 shares acquired on June 10, 2021 through automatic dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.